Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homepharmaceutical stocks

      pharmaceutical stocks

      Moderna Sues Pfizer And BioNTech Over mRNA Patent Infringement
      Investing News

      Moderna Sues Pfizer And BioNTech Over mRNA Patent Infringement

      August 29, 2022
      Omicron-Based Booster: Pfizer and BioNTech Seeking EU Approval
      Investing News

      Omicron-Based Booster: Pfizer and BioNTech Seeking EU Approval

      August 29, 2022
      Should Pfizer Shareholders be Concerned About Declining Demand for COVID-19 Vaccine?
      Trading Tips

      Should Pfizer Shareholders be Concerned About Declining Demand for COVID-19 Vaccine?

      August 26, 2022
      Battle for mRNA technology, Moderna sues Pfizer and BioNTech for patent infringement
      Investing News

      Battle for mRNA technology, Moderna sues Pfizer and BioNTech for patent infringement

      August 26, 2022
      Japan Approves AstraZeneca’s Request to Widen Use of 3 Drugs
      Investing News

      Japan Approves AstraZeneca’s Request to Widen Use of 3 Drugs

      August 25, 2022
      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.
      Investing News

      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.

      August 25, 2022
      Annovis Bio’s Phase III Dosing Begins for Parkinson’s Study
      Investing News

      Annovis Bio’s Phase III Dosing Begins for Parkinson’s Study

      August 25, 2022
      Eli Lilly Shares Are Up More Than 15% So Far This Year. What’s Next?
      Investing News

      Eli Lilly Shares Are Up More Than 15% So Far This Year. What’s Next?

      August 25, 2022
      How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs
      Investing News

      How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs

      August 24, 2022
      Arrowhead Pharmaceuticals and Johnson & Johnson To Share Potentially Exciting News
      Investing News

      Arrowhead Pharmaceuticals and Johnson & Johnson To Share Potentially Exciting News

      August 24, 2022
      « 1 … 14 15 16 17 18 … 21 »

       

      LATEST NEWS

      • Investing News Broadcom Stock Dips Amid AI Market Shift
      • Investing News Broadcom Stock Misinterpretation Impact
      • Investing News Broadcom’s Strong Q4 2025 Earnings
      • Investing News Costco’s Q1 2026 Earnings Surpass Expectations
      • Investing News Oracle’s Strong Q2 Earnings Report

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025